Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMILE: Personalized Biologics Selection in Psoriasis and Psoriatic Arthritis
NCT07149792Phase 4Recruiting
- Sponsor
- Taichung Veterans General Hospital
- Start
- Jul 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in psoriasis and psoriatic arthritis (PsA) (2 arms), sponsored by Taichung Veterans General Hospital. Primary endpoints: Psoriasis Area and Severity Index at 48 weeks, Disease Activity in Psoriatic Arthritis Score at 48 weeks and 2 more. Started Jul 2025; status: recruiting.
02
Conditions
psoriasispsoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT07149792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07149792.